Skip to main content

PerkinElmer Launches Sales and Service Operation in India with Labindia

NEW YORK, April 26 (GenomeWeb News) - PerkinElmer and Labindia Instruments have jointly launched PerkinElmer India, a direct sales, service, and marketing operation targeting India's life science and analytical instrumentation markets, the companies said today.


PerkinElmer holds a majority stake in the joint venture, which will be headquartered in Thane, India and will employ about 180 people.


"India represents a key growth market for a number of PerkinElmer businesses, including biopharma, environmental and chemical, and genetic screening," Peter Coggins, president of PerkinElmer's life and analytical sciences unit, said in a statement. "We are pleased to be working with Labindia to bring ... our ... product and service portfolio to India's rapidly expanding community of scientists and researchers."


The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.